New Study in Nature: Green Tea EGCG Shows Potent Anti-Metastatic Properties in Cancer Models

Title: New Study in Nature: Green Tea EGCG Shows Potent Anti-Metastatic Properties in Cancer Models

Meta Description: A new study in Nature reveals Green Tea EGCG's anti-metastatic properties. Blue Eyes Biotech provides 98% pure EGCG for advanced cancer support formulations.

Article:

Groundbreaking research published in Nature Cell Biology in 2024 has elucidated the potent anti-metastatic mechanism of Epigallocatechin-3-gallate (EGCG),

the most bioactive catechin in green tea. The study identified that EGCG directly inhibits the formation of invadopodia, actin-rich protrusions

that cancer cells use to degrade the extracellular matrix and initiate metastasis. By suppressing a key signaling protein called Cortactin,

EGCG effectively "paralyzes" the invasive capacity of cancer cells, preventing them from spreading to secondary sites.

This discovery positions EGCG as a premier natural compound for preventing cancer recurrence and progression. Blue Eyes Biotech CO., Ltd.

enables the practical application of this discovery by supplying a highly concentrated Green Tea Extract standardized to a minimum of

98% EGCG. Our extraction process preserves the integrity of the delicate catechin profile, ensuring maximum biological activity.

For brands developing cutting-edge supplements for cancer survivors or those at high risk, the purity of the EGCG ingredient is paramount.

Blue Eyes Biotech guarantees this purity through rigorous HPLC testing, with each batch accompanied by a Certificate of Analysis

confirming the 98% EGCG content and the absence of caffeine and contaminants. Our technical team can provide formulation support to

ensure the stability of EGCG in final products, as it is sensitive to heat and pH. By sourcing our high-purity EGCG, nutraceutical companies

can create scientifically sophisticated products that directly target the metastatic process, addressing a critical unmet need in oncology

support. Visit www.blueeyes-bio.com to learn more.